News Releases

Thursday, October 16, 2014

UH Infection Control: Ebola Preparedness Plan is in Place

If a person suspected of having Ebola were to seek care at a University Hospitals facility, UH is prepared. That's the message from Amy Ray, MD, MPH, an infectious disease specialist who has chaired the University Hospitals System Infection Control Committee since 2008.

"If a patient presents for care, we are prepared to deliver safe care. We will continue to remain vigilant to identify patients at risk, at or before the point of care, and provide our health care personnel with the optimal personal protective equipment," she says. "Given global travel, it is within the realm of possibility that a patient may seek care at our facilities."



Tuesday, October 07, 2014

Foundation Fighting Blindness and Harrington Discovery Institute partner to accelerate drug development for critical causes of blindness

Columbia, MD/Cleveland, OH – The Foundation Fighting Blindness in Columbia, MD, and Harrington Discovery Institute in Cleveland, OH, announce a new nationwide initiative, “The Gund-Harrington National Initiative for Fighting Blindness,” focused on finding treatments and cures for people affected by inherited retinal diseases that lead to blindness. More than 10 million Americans, and many more times that number worldwide, of every age and race suffer vision loss from this type of eye disease.

“It is a great honor to team up on a shared mission with the Gordon and Lulie Gund family, the Foundation Fighting Blindness and University Hospitals,” said Ron Harrington, who along with his wife, Nancy; daughter, Jill; and son and daughter-in-law, Ron and Lydia, made a gift of $50 million in 2012 to launch the Harrington Discovery Institute. “It is deeply meaningful for our family to share Gordon and Lulie Gund’s longtime philanthropic mission and passion.” 


Thursday, September 25, 2014

New research outlines promising therapies for small cell lung cancer

CLEVELAND –  Two recently published studies by a research team at University Hospitals (UH) Case Medical Center Seidman Cancer Center have the potential to advance treatments for small cell lung cell cancer (SCLC). This aggressive form of lung cancer has seen no treatment advances in 30 years and “is a disease in urgent need of new drug therapies,” write the study’s authors.
 
“In small cell lung cancer, which impacts about 30-40,000 people each year in the United States, there has been no therapeutic progress and very little research,” says Afshin Dowlati, MD, lead author and Director of the Center for Cancer Drug Development at UH Seidman Cancer Center. “Additionally, there are no approved targeted therapies for the disease. These studies lay the foundation for future research aimed at finding important new treatments for this highly malignant cancer.”
 
A study titled, RET Mutation and Expression in Small Cell Lung Cancer, was published in the September issue of Journal of Thoracic Oncology and found a new mutation in SCLC which may play a role in the disease’s development. The researchers found that the genetic mutation, called RET (rearranged during transfection), was linked to rapid cell growth.


Wednesday, August 27, 2014

University Hospitals Case Medical Center partners with ImPACT Applications to offer comprehensive concussion management program

CLEVELAND – University Hospitals (UH) Case Medical Center has entered into a partnership with ImPACT Applications, Inc., developer of the ImPACT© Test and ImPACT Concussion Management Model, to improve concussion prevention, identification and treatment for athletes and individuals in the Cleveland area.
 
UH is using ImPACT neurocognitive baseline and post-injury testing in all schools with UH physicians and/or athletic trainers. UH plans on conducting 10,000 baseline tests on high school student athletes.  As part of the implementation, the UH clinical team will participate in intensive training on ImPACT test administration and the application of all aspects of ImPACT's Concussion Management Model. UH is working toward having 10 physicians as Certified ImPACT Consultants (CICs) and 10 ImPACT Trained Athletic Trainers (ITATs), in recognition of the training and education they will receive.


Thursday, August 21, 2014

UH Case Medical Center’s Dr. Parikh authors SCAI paper on treatment of renal artery stenosis

CLEVELAND – Renal artery stenting to open blockages in the kidney arteries may benefit patients who have historically been excluded from modern clinical trials, according to new recommendations for renal artery stenosis e-published in Catheterization and Cardiovascular Interventions today by the Society for Cardiovascular Angiography and Interventions (SCAI).

University Hospitals Case Medical Center’s Sahil Parikh, MD, Director, Interventional Cardiology Fellowship Program and Professor of Medicine, Case Western Reserve University School of Medicine was the lead author on the paper that details possible assessment and treatment guidelines for renal artery disease.
 
Blockages in the kidney (renal) arteries are often asymptomatic, but may lead to high blood pressure or worsening of high blood pressure control. If left untreated, the disease can cause kidney failure and heart failure. Optimal medical therapy remains the preferred first-line treatment. 



You must be logged in to view this item.



Login

This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.